Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment for Moderate to Severe Glabellar Lines

201931 citationsJournal Article

Authors

Gary D. Monheit · University of Alabama at Birmingham

Abstract

Most ABO-treated subjects sustained ≥1 grade glabellar line improvements over 120 days, and satisfaction was maintained by >30% of subjects throughout 150 days. ABO was well tolerated.

Topics & Keywords

Botulinum Toxin and Related Neurological Disorders Pain Mechanisms and Treatments Cancer Treatment and Pharmacology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Dermatologic Surgery

Volume 46, Issue 1, pp. 61-69

DOI: 10.1097/dss.0000000000002013

Field-Weighted Citation Impact: 2.29